Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function

NCT00386750 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 265

Last updated 2012-04-27

No results posted yet for this study

Summary

THIS STUDY IS NOT ENROLLING PATIENTS IN THE USA.

To evaluate the effects of artemether/ lumefantrine on the auditory function.

Conditions

Interventions

DRUG

Artemether-lumefantrine

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2005-11-30
Completion
2005-11-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00386750 on ClinicalTrials.gov